產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
產(chǎn)品概述
名稱 | 22RV1 (人前列腺癌細(xì)胞) (STR鑒定正確) |
別稱 | 22RV1; 22Rv-1; 22rV1; CWR22-Rv1; CWR22R-V1; CWR22-R1; CWR22Rv1; CWR22R |
種屬 | 人 |
生長特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:90%FBS+10%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:3-1:4 |
推薦換液頻率 | 2-3次/周 |
注意事項 | 22RV1細(xì)胞復(fù)蘇時需要離心去除DMSO。凍存細(xì)胞復(fù)蘇最初階段,貼壁量少,成簇松散貼壁,但是最終細(xì)胞會變平并且擴(kuò)散成很好的單層,這個過程需要4-5天時間。細(xì)胞生長緩慢,細(xì)胞只能生長到90%的匯合度。細(xì)胞凍存后復(fù)蘇成活率不高,推薦凍存液配比為90%FBS+10% DMSO,使用優(yōu)質(zhì)血清。 |
背景描述 | 22RV1是來自異種移植(在閹割引起前列腺癌衰退又在其父親的雄性激素信賴型CWR22嫁接后復(fù)發(fā)的小鼠中連續(xù)傳代)的人前列腺癌上皮細(xì)胞系;22RV1細(xì)胞系表達(dá)前列腺特異抗原。二羥基睪丸脂酮輕微刺激22RV1細(xì)胞生長,經(jīng)Western Blot檢測溶解產(chǎn)物與抗雄性激素受體抗體起免疫反應(yīng);EGF刺激22RV1細(xì)胞生長,但TGFβ-1不能抑制細(xì)胞生長;22RV1可在裸鼠中成瘤。 |
年齡(性別) | 男性 |
組織來源 | 前列腺 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 前列腺癌細(xì)胞 |
生物安全等級 | BSL-2 |
倍增時間 | ~40 hours |
致瘤性 | Yes, forms tumors in nude mice. |
受體表達(dá)情況 | androgen receptor |
保藏機(jī)構(gòu) | ATCC; CRL-2505 BCRC; 60545 DSMZ; ACC-438 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X,Y CSF1PO 10,11 D2S1338 17,18 D3S1358 15 D5S818 11,13 D7S820 9,10,11 D8S1179 13,14 D13S317 9,12 D16S539 12 D18S51 13,14 D19S433 13,14 D21S11 30 FGA 19,23 PentaD 9,12 PentaE 5,13 TH01 6,9.3 TPOX 8 vWA 15,21 D6S1043 16 D12S391 18,25 D2S441 11,12 -
STR鑒定圖
-
參考文獻(xiàn)
-
Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma (2025-02-22)
期刊:Nature Communications
DOI:10.1038/s41467-025-57190-1
影響因子 :14.7
引用產(chǎn)品: PC-3 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
-
Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1 (2025-01-16)
期刊:MOLECULAR MEDICINE
DOI:10.1186/s10020-025-01073-0
影響因子 :6.0
引用產(chǎn)品: PC-3 細(xì)胞 , DU 145 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
-
157Gd-DOTA-PSMA as theranostic bio-gadolinium agent for prostate cancer targeted gadolinium neutron capture therapy (2025-02-25)
期刊:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI:10.1007/s00432-025-06136-7
影響因子 :2.7
引用產(chǎn)品: 22RV1 細(xì)胞 , PC-3 細(xì)胞
-
Genetically Engineered Membrane-Coated Nanoparticles for?Enhanced Prostate-Specific Membrane Antigen Targeting and Ferroptosis Treatment of Castration-Resistant Prostate Cancer (2024-07-01)
期刊:Advanced Science
影響因子 :14.3
引用產(chǎn)品: 22RV1 細(xì)胞
-
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer (2024-06-11)
期刊:CANCER RESEARCH
DOI:10.1158/0008-5472.CAN-23-3704
影響因子 :12.5
引用產(chǎn)品: PC-3 細(xì)胞 , 22RV1 細(xì)胞 , DU 145 細(xì)胞 , RM-1 細(xì)胞 , C4-2 細(xì)胞
-
Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer (2024-03-21)
期刊:CELL DEATH AND DIFFERENTIATION
DOI:10.1038/s41418-024-01282-w
影響因子 :12.4
引用產(chǎn)品: C4-2 細(xì)胞 , 22RV1 細(xì)胞 , PC-3 細(xì)胞 , DU 145 細(xì)胞
-
METTL3-mediated m6A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy (2024-08-14)
期刊:CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI:10.1186/s11658-024-00628-z
影響因子 :9.2
引用產(chǎn)品: DU 145 細(xì)胞 , PC-3 細(xì)胞 , 22RV1 細(xì)胞
-
Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma (2024-09-11)
期刊:Stem Cell Research & Therapy
DOI:10.1186/s13287-024-03917-8
影響因子 :7.1
引用產(chǎn)品: VCaP 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , PC-3 細(xì)胞 , 22RV1 細(xì)胞
-
Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor (2024-06-18)
期刊:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1016/j.ejmech.2024.116612
影響因子 :6.0
引用產(chǎn)品: KATO III [KATO 3] 細(xì)胞 , AN3 CA 細(xì)胞 , A2780 細(xì)胞 , BxPC-3 細(xì)胞 , MCF7 [MCF-7] 細(xì)胞 , HuH-7 細(xì)胞 , MDA-MB-231 細(xì)胞 , HCT 116 細(xì)胞 , 22RV1 細(xì)胞 , HL-7702 [L-02; LO2] 細(xì)胞 , 293 [HEK-293] 細(xì)胞 , 293T [HEK-293T] 細(xì)胞 , NCI-H1975 細(xì)胞
-
YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation (2024-03-09)
期刊:JOURNAL OF BIOLOGICAL CHEMISTRY
影響因子 :4.8
引用產(chǎn)品: PC-3 細(xì)胞 , DU 145 細(xì)胞 , 22RV1 細(xì)胞 , Ham's F-12K 培養(yǎng)基 , MEM (含NEAA) 培養(yǎng)基 , RPMI-1640 培養(yǎng)基
-
Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics (2024-04-19)
期刊:JOURNAL OF ETHNOPHARMACOLOGY
影響因子 :4.8
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞 , PC-3 細(xì)胞 , DU 145 細(xì)胞
-
Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation (2024-03-28)
期刊:ENVIRONMENTAL TOXICOLOGY
影響因子 :4.5
引用產(chǎn)品: PC-3 細(xì)胞 , 22RV1 細(xì)胞
-
Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs (2024-08-08)
期刊:EUROPEAN JOURNAL OF MEDICAL RESEARCH
DOI:10.1186/s40001-024-02000-5
影響因子 :2.8
引用產(chǎn)品: BPH-1 細(xì)胞 , C4-2 細(xì)胞 , PC-3 細(xì)胞 , RWPE-1 細(xì)胞 , DU 145 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
-
CRABP2 promotes cell migration and invasion by activating PI3K/AKT and MAPK signaling pathways via up-regulating LAMB3 in prostate cancer (2024-07-22)
期刊:JOURNAL OF BIOCHEMISTRY
影響因子 :2.1
引用產(chǎn)品: RPMI-1640 培養(yǎng)基 , PC-3 細(xì)胞 , 22RV1 細(xì)胞 , 青霉素-鏈霉素溶液(雙抗),100× , LNCaP clone FGC 細(xì)胞 , DMEM高糖 培養(yǎng)基 , DU 145 細(xì)胞 , 特級胎牛血清 , MEM 培養(yǎng)基
-
A morpholine derivative N-(4-morpholinomethylene)ethanesulfonamide induces ferroptosis in tumor cells by targeting NRF2 (2024-01-30)
期刊:BIOLOGICAL & PHARMACEUTICAL BULLETIN
影響因子 :2.0
引用產(chǎn)品: 22RV1 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , C4-2 細(xì)胞 , SK-OV-3 細(xì)胞
-
Circ_0006220 (circ-TADA2A) accelerates prostate cancer cell malignant behaviors through miR-520f-3p/CDCA7 axis (2024-07-28)
期刊:CELLULAR AND MOLECULAR BIOLOGY
影響因子 :1.5
引用產(chǎn)品: 22RV1 細(xì)胞 , RWPE-1 細(xì)胞 , DMEM高糖完全培養(yǎng)基(含10% FBS) , SILAC RPMI-1640 培養(yǎng)基 , DU 145 細(xì)胞 , VCaP 細(xì)胞 , PC-3 細(xì)胞 , Ham's F-12完全培養(yǎng)基(含10% FBS)
-
Synthesis of curcumin derivatives for suppression of castration-resistant prostate cancer (2024-02-06)
期刊:JOURNAL OF CHEMICAL RESEARCH
影響因子 :1.4
引用產(chǎn)品: 22RV1 細(xì)胞
-
A Pegylated Liposome Loaded with Raddeanin A for Prostate Cancer Therapy (2023-07-21)
期刊:International Journal of Nanomedicine
影響因子 :8.0
引用產(chǎn)品: RM-1 細(xì)胞 , 22RV1 細(xì)胞
-
AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression (2023-11-23)
期刊:iScience
DOI:10.1016/j.isci.2023.108523
影響因子 :5.8
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , PC-3 細(xì)胞 , 22RV1 細(xì)胞
-
A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients (2023-03-14)
期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影響因子 :5.6
引用產(chǎn)品: RWPE-1 細(xì)胞 , 22RV1 細(xì)胞 , PC-3 細(xì)胞 , DU 145 細(xì)胞 , DU 145細(xì)胞專用培養(yǎng)基 , PC-3細(xì)胞專用培養(yǎng)基
-
Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer (2023-07-25)
期刊:Aging-US
影響因子 :5.2
引用產(chǎn)品: PC-3 細(xì)胞 , DU 145 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞 , RPMI-1640 培養(yǎng)基
-
177Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer (2023-12-28)
期刊:MOLECULAR PHARMACEUTICS
DOI:10.1021/acs.molpharmaceut.3c00987
影響因子 :4.9
引用產(chǎn)品: 22RV1 細(xì)胞 , PC-3 細(xì)胞
-
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer (2023-08-16)
期刊:FASEB JOURNAL
影響因子 :4.8
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , PC-3 細(xì)胞 , 22RV1 細(xì)胞
-
USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma (2023-07-26)
期刊:MOLECULAR CARCINOGENESIS
DOI:10.1002/mc.23609
影響因子 :4.6
引用產(chǎn)品: 22RV1 細(xì)胞 , DU 145 細(xì)胞 , PC-3M 細(xì)胞 , VCaP 細(xì)胞
-
Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing (2023-06-07)
期刊:Diagnostics
DOI:10.3390/diagnostics13121997
影響因子 :3.6
引用產(chǎn)品: C4-2 細(xì)胞 , 22RV1 細(xì)胞 , DU 145 細(xì)胞 , PC-3 細(xì)胞
-
IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer (2023-08-07)
期刊:PROSTATE
影響因子 :2.8
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , C4-2 細(xì)胞 , 22RV1 細(xì)胞 , PC-3 細(xì)胞
-
Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer (2023-04-12)
期刊:PeerJ
影響因子 :2.7
引用產(chǎn)品: PC-3 細(xì)胞 , DU 145 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
-
Circular RNA Dipeptidyl Peptidase 4 (circDPP4) Stimulates the Expression of Glutamate Dehydrogenase 1 to Contribute to the Malignant Phenotypes of Prostate Cancer by Sponging miR-497-5p (2023-04-20)
期刊:MOLECULAR BIOTECHNOLOGY
DOI:10.1007/s12033-023-00750-x
影響因子 :2.6
引用產(chǎn)品: 22RV1 細(xì)胞 , RWPE-1 細(xì)胞 , RPMI-1640 培養(yǎng)基
-
Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer (2022-09-01)
期刊:Cell Death & Disease
DOI:10.1038/s41419-022-05182-0
影響因子 :9.7
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , VCaP 細(xì)胞 , 22RV1 細(xì)胞
-
Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer (2022-11-29)
期刊:Cell Death Discovery
DOI:10.1038/s41420-022-01257-1
影響因子 :7.1
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , C4-2 細(xì)胞 , 22RV1 細(xì)胞
-
Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors (2022-12-07)
期刊:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1016/j.ejmech.2022.115004
影響因子 :7.1
引用產(chǎn)品: 22RV1 細(xì)胞 , MM.1S 細(xì)胞 , MV-4-11 細(xì)胞 , JeKo-1 細(xì)胞 , 4T1 細(xì)胞 , DMEM高糖 培養(yǎng)基
-
Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor-promoted inflammatory responses and prostate cancer progression (2022-10-17)
期刊:FASEB JOURNAL
影響因子 :5.8
引用產(chǎn)品: 22RV1 細(xì)胞 , C4-2 細(xì)胞
-
HMGB1 promotes the development of castration?resistant prostate cancer by regulating androgen receptor activation (2022-09-19)
期刊:ONCOLOGY REPORTS
影響因子 :4.1
引用產(chǎn)品: LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
-
GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer (2022-10-25)
期刊:PeerJ
影響因子 :3.1
引用產(chǎn)品: PC-3 細(xì)胞 , DU 145 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
-
LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway (2021-08-19)
期刊:Journal Of Cellular And Molecular Medicine
影響因子 :5.3
引用產(chǎn)品: C4-2 細(xì)胞 , PC-3 細(xì)胞 , 22RV1 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , DU 145 細(xì)胞
-
MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways (2021-11-10)
期刊:Journal Of Cellular And Molecular Medicine
影響因子 :5.3
引用產(chǎn)品: DU 145 細(xì)胞 , PC-3 細(xì)胞 , LNCaP clone FGC 細(xì)胞 , 22RV1 細(xì)胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識別碼示意圖